Erratum: Predictors of chronic kidney disease in type 2 diabetes: A longitudinal study from the AMD Annals initiative (Medicine and Science in Sports and Exercise (2016) 95:27 (e4007) DOI: 10.1097/MD.0000000000004007);Predictors of chronic kidney disease in type 2 diabetes: A longitudinal study from the AMD Annals initiative

Medicine (United States)

Volumn 95, Issue 27, 2016, Pages e5660-

  De Cosmo, Salvatore ^a   Viazzi, Francesca ^b   Pacilli, Antonio ^a   Giorda, Carlo ^c   Ceriello, Antonio ^d   Gentile, Sandro ^e   Russo, Giuseppina ^f   Rossi, Maria C ^g   Nicolucci, Antonio ^h   Guida, Pietro ^h   Pontremoli, Roberto ^b  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c Diabetes and Metabolism Unit ASL Turin 5   (Italy)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

^e SECOND UNIVERSITY OF NAPLES   (Italy)

^f UNIVERSITY OF MESSINA   (Italy)

^g Center for Outcomes Research and Clinical Epidemiology   (Italy)

^h Statistical Consultant for Associazione Medici Diabetologi (AMD)   (Italy)

Author keywords

albuminuria; diabetic kidney disease; glomerular filtration rate; risk factors; type 2 diabetes

Indexed keywords

ALBUMIN; ANTIHYPERTENSIVE AGENT; CREATININE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; BIOLOGICAL MARKER;

ADULT; ALBUMINURIA; ANTIHYPERTENSIVE THERAPY; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL FEATURE; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; FEMALE; GLOMERULUS FILTRATION RATE; GLYCEMIC CONTROL; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; AGED; COMPLICATION; DIABETES MELLITUS, TYPE 2; ITALY; KIDNEY FUNCTION TEST; LONGITUDINAL STUDY; MIDDLE AGED; PREDICTIVE VALUE; RENAL INSUFFICIENCY, CHRONIC; RISK FACTOR;

AGED; ALBUMINURIA; BIOMARKERS; DIABETES MELLITUS, TYPE 2; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; ITALY; KIDNEY FUNCTION TESTS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 84978654520     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000005660     Document Type: Erratum

References (33)

1. IDFDiabetes Atlas. 6th ed.2013;Brussels, Belgium:International Diabetes Federation, http://www.idf.org/diabetesatlashttp://www.idf.org/diabete satlas. Accessed July 16, 2015
2. Guariguata L, Whiting DR, Hambleton I, et al. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract 2014;103:137-49
3. US Renal Data SystemRenal Data US System USRDS 2014 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD:US Renal Data System; 2014
4. National Kidney FoundationKDOQI clinical practice guidelines for Diabetes and CKD: 2012 update. Am J Kidney Dis 2012;60:850-86
5. De Boer IH, Rue TC, Hall YN, et al. Temporal trends in the prevalence of diabetic kidney disease in the United States. JAMA 2011;305:2532-9
6. Matsushita K, Coresh J, Sang Y, et al. Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data. Lancet Diabetes Endocrinol 2015;3:514-25
7. Fox CS, Matsushita K, Woodward M, et al. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet 2012; 380:1662-73
8. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work GroupKDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 2013;3:1-50
9. Krolewski AS, Warram JH, Christlieb AR, et al. The changing natural history of nephropathy in type I diabetes. Am J Med 1985;78:785-94
10. De Cosmo S, Rossi MC, Pellegrini F, et al. Kidney dysfunction and related cardiovascular risk factors among patients with type 2 diabetes. Nephrol Dial Transplant 2014;29:657-62
11. Thomas MC, MacIsaac RJ, Jerums G, et al. Nonalbuminuric renal impairment in type 2 diabetic patients and in the general population (National Evalution of the Frequency of Renal Impairment cO-existing with NIDDM [NEFRON] 11). Diabetes Care 2009;32:1497-502
12. Dwyer JP, Parving HH, Hunsicker LG, et al. Renal dysfunction in the presence of normoalbuminuria in type 2 diabetes: results from the DEMAND study. Cardiorenal Med 2012;2:1-0
13. De Cosmo S, Lamacchia O, Pacilli A, et al. Normoalbuminuric renal impairment and all-cause mortality in type 2 diabetes mellitus. Acta Diabetol 2014;51:687-9
14. Fox CS,Matsushita K, Wooward M, et al. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet 2012;380:1662-73
15. Nicolucci A, Rossi MC, Arcangeli A, et al. Four-year impact of a continuous quality improvement effort implemented by a network of diabetes outpatient clinics: the AMD-Annals initiative. Diabet Med 2010;27:1041-8
16. De Cosmo S, Viazzi F, Pacilli A, et al. Serum uric acid and risk of chronic kidney disease in type 2 diabetes: the AMD Annals initiative. CJASN 2015. CJN.03140315
17. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604-12
18. Coresh J, Turin TC, Matsushita K, et al. Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. JAMA 2014;311:2518-31
19. Adler AI, Stevens RJ, Manley SE, et al. on behalf of the UKPDS GROUP Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int 2003;63:225-32
20. Retnakaran R, Cull CA, Thorne KI, et al. UKPDS Study GroupRisk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74. Diabetes 2006;55:1832-9
21. Bruno G,Merletti F, Biggeri A, et al. Progression to overt nephropathy in type 2 diabetes: the Casale Monferrato Study. Diabetes Care 2003;26: 2150-5
22. Rossing K, Christensen PK, Hovind P, et al. Progression of nephropathy in type 2 diabetic patients. Kidney Int 2004;66:1596-605
23. USRDS Annual report 2015. Available at: http://www.usrds.org/adr. aspx (accessed May 22, 2016)
24. Shastri S, Katz R, Shlipak MG, et al. Cystatin C and albuminuria as risk factors for development of CKD stage 3: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Kidney Dis 2011;57:832-40
25. Zoppini G, Targher G, Chonchol M, et al. Predictors of Estimated GFR Decline in Patients with Type 2 Diabetes and Preserved Kidney Function. Clin J Am Soc Nephrol 2012;7:401-8
26. Parving HH, Lewis JB, Ravid M, et al. DEMAND Investigators. Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective. Kidney Int 2006;69: 2057-63
27. Rossi MC, Nicolucci A, Pellegrini F, et al. Identifying patients with type 2 diabetes at high risk of microalbuminuria: results of the DEMAND (Developing Education on Microalbuminuria for Awareness of reNal and cardiovascular risk in Diabetes) Study. Nephrol Dial Transplant 2008;23:1278-84
28. Takagi M, Babazono T, Uchigata Y. Differences in risk factors for the onset of albuminuria and decrease in glomerular filtration rate in people with type 2 diabetes mellitus: implications for the pathogenesis of diabetic kidney disease. Diabet Med 2015;32:1354-60
29. Penno G, Solini A, Bonora E, et al. Clinical significance of nonalbuminuric renal impairment in type 2 diabetes. J Hypertens 2011; 29:1802-9
30. Chen J, Muntner P, Hamm LL, et al. The metabolic syndrome and chronic kidney disease in US adults. Ann Intern Med 2004;140:167-74
31. Cosmo S, Menzaghi C, Prudente S, et al. Role of insulin resistance in kidney dysfunction: insights into the mechanism and epidemiological evidence. Nephrol Dial Transplant 2013;28:29-36
32. Penno G, Solini A, Zoppini G, et al. Hypertriglyceridemia is independently associated with renal, but not retinal complications in subjects with type 2 diabetes: a cross-sectional analysis of the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study. PLoS One 2015;10:e0125512
33. Bhalla V, Zhao B, Azar KM, et al. Racial/ethnic differences in the prevalence of proteinuric and nonproteinuric diabetic kidney disease. Diabetes Care 2013;36:1215-21